71.50
前日終値:
$71.64
開ける:
$71.23
24時間の取引高:
1.47M
Relative Volume:
0.60
時価総額:
$11.40B
収益:
$705.14M
当期純損益:
$-453.90M
株価収益率:
-23.52
EPS:
-3.04
ネットキャッシュフロー:
$-551.29M
1週間 パフォーマンス:
-1.23%
1か月 パフォーマンス:
+16.53%
6か月 パフォーマンス:
+146.30%
1年 パフォーマンス:
+84.85%
Ionis Pharmaceuticals Inc Stock (IONS) Company Profile
名前
Ionis Pharmaceuticals Inc
セクター
電話
(760) 931-9200
住所
2855 GAZELLE COURT, CARLSBAD, CA
IONS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IONS
Ionis Pharmaceuticals Inc
|
71.50 | 11.42B | 705.14M | -453.90M | -551.29M | -3.04 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
426.44 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.90 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
584.74 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
814.17 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.54 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-10-08 | アップグレード | JP Morgan | Neutral → Overweight |
2025-09-26 | アップグレード | Goldman | Sell → Neutral |
2025-09-03 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2025-07-31 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2025-07-01 | アップグレード | Barclays | Equal Weight → Overweight |
2025-04-07 | 開始されました | H.C. Wainwright | Buy |
2025-03-31 | 開始されました | Redburn Atlantic | Neutral |
2024-08-02 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2024-07-24 | アップグレード | Leerink Partners | Market Perform → Outperform |
2024-07-16 | 再開されました | Jefferies | Buy |
2024-06-14 | アップグレード | Bernstein | Underperform → Mkt Perform |
2024-04-10 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2024-01-02 | アップグレード | BofA Securities | Neutral → Buy |
2023-10-23 | アップグレード | BofA Securities | Underperform → Neutral |
2023-09-29 | 開始されました | Raymond James | Strong Buy |
2023-07-31 | アップグレード | Citigroup | Neutral → Buy |
2023-06-07 | 再開されました | Piper Sandler | Overweight |
2023-05-04 | アップグレード | Citigroup | Sell → Neutral |
2023-03-21 | 開始されました | Bernstein | Underperform |
2022-12-21 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2022-09-09 | 再開されました | Morgan Stanley | Overweight |
2022-07-18 | 再開されました | Oppenheimer | Outperform |
2022-03-31 | 再開されました | Piper Sandler | Overweight |
2022-03-01 | 開始されました | Citigroup | Sell |
2022-03-01 | 開始されました | Guggenheim | Buy |
2022-02-01 | ダウングレード | BofA Securities | Buy → Underperform |
2021-12-14 | アップグレード | William Blair | Mkt Perform → Outperform |
2021-05-07 | アップグレード | UBS | Sell → Neutral |
2021-03-01 | アップグレード | Barclays | Underweight → Equal Weight |
2020-12-16 | 開始されました | UBS | Sell |
2020-12-15 | アップグレード | Cowen | Market Perform → Outperform |
2020-09-14 | 再開されました | JP Morgan | Neutral |
2020-09-02 | 開始されました | The Benchmark Company | Hold |
2020-06-01 | 再開されました | Oppenheimer | Outperform |
2020-05-13 | 開始されました | RBC Capital Mkts | Outperform |
2020-03-05 | 開始されました | Citigroup | Buy |
2019-12-13 | 開始されました | Oppenheimer | Outperform |
2019-11-13 | 開始されました | BofA/Merrill | Buy |
2019-11-07 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2019-09-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
2018-08-08 | 繰り返されました | Stifel | Hold |
2018-08-07 | 繰り返されました | Stifel | Hold |
2018-05-08 | ダウングレード | Evercore ISI | Outperform → In-line |
2017-10-06 | 再開されました | Goldman | Sell |
2017-08-17 | 開始されました | Evercore ISI | Outperform |
2017-08-09 | 繰り返されました | Stifel | Hold |
2017-03-10 | ダウングレード | Goldman | Neutral → Sell |
2016-12-28 | 繰り返されました | BMO Capital Markets | Outperform |
2016-12-27 | 繰り返されました | Leerink Partners | Mkt Perform |
すべてを表示
Ionis Pharmaceuticals Inc (IONS) 最新ニュース
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
What is the fair value estimate for Ionis Pharmaceuticals Inc. (ISI) stock in 20252025 Fundamental Recap & High Accuracy Investment Signals - newser.com
Published on: 2025-10-21 21:59:51 - newser.com
Can Ionis Pharmaceuticals Inc. (ISI) stock sustain revenue momentumBond Market & Real-Time Stock Entry Alerts - newser.com
Sector ETF performance correlation with Ionis Pharmaceuticals Inc.Portfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Ionis CEO Brett P. Monia receives 2025 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society - Business Wire
Is Ionis Pharmaceuticals Inc. stock poised for growth2025 Price Momentum & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-10-21 01:16:00 - newser.com
Ionis Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - newser.com
Can Ionis Pharmaceuticals Inc. stock resist market sell offsNew Guidance & Community Trade Idea Sharing - newser.com
Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares - The Motley Fool
News impact scoring models applied to Ionis Pharmaceuticals Inc.July 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Is Ionis Pharmaceuticals Inc. (ISI) stock resilient in recession scenariosIPO Watch & Verified Technical Signals - nchmf.gov.vn
Can you recover from losses in Ionis Pharmaceuticals Inc.Portfolio Return Report & Smart Allocation Stock Tips - newser.com
Is Ionis Pharmaceuticals Inc. stock ready for breakoutJuly 2025 Outlook & Consistent Profit Alerts - newser.com
Will Ionis Pharmaceuticals Inc. stock deliver better than expected guidanceTrade Ideas & Verified Technical Signals - newser.com
Is Ionis Pharmaceuticals Inc. building a consolidation baseEarnings Performance Report & Weekly High Return Stock Forecasts - newser.com
Why ETFs are accumulating Ionis Pharmaceuticals Inc. (ISI) stockGold Moves & Safe Capital Allocation Plans - newser.com
What recovery options are there for Ionis Pharmaceuticals Inc.July 2025 Setups & Detailed Earnings Play Strategies - newser.com
Should Ionis Pharmaceuticals' (IONS) Raised Revenue Guidance and Strong Q2 Results Prompt Investor Action? - Sahm
Can Ionis Pharmaceuticals Inc. stock weather global recessionTrade Exit Summary & Technical Entry and Exit Tips - nchmf.gov.vn
Layoff Watch: Can Ionis Pharmaceuticals Inc. stock weather global recessionJuly 2025 PostEarnings & Stepwise Trade Signal Guides - nchmf.gov.vn
Will Ionis Pharmaceuticals Inc. stock sustain high P E ratiosRecession Risk & Advanced Swing Trade Entry Plans - nchmf.gov.vn
Bear Alert: Is Ionis Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Trade Report & Smart Money Movement Tracker - nchmf.gov.vn
Hedge Fund and Insider Trading News: Scott Bessent, Paul Tudor Jones, Crispin Odey, Ken Griffin, Millennium Management, Ionis Pharmaceutical Inc (IONS), Chicago Atlantic Real Estate Finance Inc (REFI), and More - Insider Monkey
CapEx per share of Ionis Pharmaceuticals, Inc. – DUS:ISI - TradingView
Ionis Pharmaceuticals Insider Sold Shares Worth $1,723,987, According to a Recent SEC Filing - MarketScreener
Ionis Pharmaceuticals director Parshall sells $358,721 in stock By Investing.com - Investing.com Australia
Ionis Pharmaceuticals EVP Birchler sells $1.72m in shares By Investing.com - Investing.com Australia
Insider Sell Alert: B Parshall Sells 5,000 Shares of Ionis Pharm - GuruFocus
Ionis Pharma EVP Devers sells shares worth $530,636 By Investing.com - Investing.com Canada
Ionis Pharmaceuticals EVP research, Eric Swayze, sells $3901 in IONS stock - Investing.com Nigeria
Ionis Pharmaceuticals EVP Birchler sells $1.72m in shares - Investing.com
Morgan Stanley Raises Price Target for Ionis Pharmaceuticals (IO - GuruFocus
Ionis Pharmaceuticals Hits New 52-Week High of $72.15 - Markets Mojo
Ionis Pharmaceuticals Hits New 52-Week High of $73.92 - Markets Mojo
Morgan Stanley Raises Price Target on Ionis Pharmaceuticals to $90 From $86, Keeps Overweight Rating - MarketScreener
Ionis to hold third quarter 2025 financial results webcast - FinancialContent
Lobbying Update: $140,000 of IONIS PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
Ionis Pharmaceuticals Inc (IONS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):